Literature DB >> 33573312

Ethical, Legal and Social Issues (ELSI) Associated with Non-Invasive Prenatal Testing: Reflections on the Evolution of Prenatal Diagnosis and Procreative Choices.

Simona Zaami1, Alfredo Orrico2,3, Fabrizio Signore4, Anna Franca Cavaliere5, Marta Mazzi6, Enrico Marinelli1.   

Abstract

New technologies such as non-invasive prenatal testing (NIPT), capable of analyzing cell-free fetal DNA in the maternal bloodstream, have become increasingly widespread and available, which has in turn led to ethical and policy challenges that need addressing. NIPT is not yet a diagnostic tool, but can still provide information about fetal genetic characteristics (including sex) very early in pregnancy, and there is no denying that it offers valuable opportunities for pregnant women, particularly those at high risk of having a child with severe genetic disorders or seeking an alternative to invasive prenatal testing. Nonetheless, the ethical, legal and social implications (ELSI) include multiple aspects of informed decision-making, which can entail risks for the individual right to procreative autonomy, in addition to the potential threats posed by sex-selective termination of pregnancy (in light of the information about fetal sex within the first trimester), and the stigmatization and discrimination of disabled individuals. After taking such daunting challenges into account and addressing NIPT-related medicolegal complexities, the review's authors highlight the need for an ethically and legally sustainable framework for the implementation of NIPT, which seems poised to become a diagnostic tool, as its scope is likely to broaden in the near future.

Entities:  

Keywords:  aneuploidies; cell-free fetal DNA; ethical, legal and social implications; non-invasive prenatal testing; screening

Year:  2021        PMID: 33573312      PMCID: PMC7911180          DOI: 10.3390/genes12020204

Source DB:  PubMed          Journal:  Genes (Basel)        ISSN: 2073-4425            Impact factor:   4.096


  45 in total

1.  Informed decision-making in prenatal screening for Down's syndrome: what knowledge is relevant?

Authors:  H M H J D Schoonen; H M E van Agt; M L Essink-Bot; H I Wildschut; E A P Steegers; H J de Koning
Journal:  Patient Educ Couns       Date:  2010-08-25

2.  Position Statement from the Italian College of Fetal Maternal Medicine: Non-invasive prenatal testing (NIPT) by maternal plasma DNA sequencing.

Authors: 
Journal:  J Prenat Med       Date:  2013-04

3.  Will the introduction of non-invasive prenatal diagnostic testing erode informed choices? An experimental study of health care professionals.

Authors:  Ananda van den Heuvel; Lyn Chitty; Elizabeth Dormandy; Ainsley Newson; Zuzana Deans; Sophie Attwood; Shelley Haynes; Theresa M Marteau
Journal:  Patient Educ Couns       Date:  2009-06-26

4.  Mothers of a child with Down syndrome: A qualitative analysis of the perspectives on non-invasive prenatal testing.

Authors:  Chelsea Valentin; Andy Smidt; Rebecca Barton; Nathan J Wilson; Bethea How
Journal:  Midwifery       Date:  2019-06-04       Impact factor: 2.372

5.  Single-nucleotide polymorphism-based noninvasive prenatal screening in a high-risk and low-risk cohort.

Authors:  Eugene Pergament; Howard Cuckle; Bernhard Zimmermann; Milena Banjevic; Styrmir Sigurjonsson; Allison Ryan; Megan P Hall; Michael Dodd; Phil Lacroute; Melissa Stosic; Nikhil Chopra; Nathan Hunkapiller; Dennis E Prosen; Sallie McAdoo; Zachary Demko; Asim Siddiqui; Matthew Hill; Matthew Rabinowitz
Journal:  Obstet Gynecol       Date:  2014-08       Impact factor: 7.661

6.  Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening.

Authors:  Wybo Dondorp; Guido de Wert; Yvonne Bombard; Diana W Bianchi; Carsten Bergmann; Pascal Borry; Lyn S Chitty; Florence Fellmann; Francesca Forzano; Alison Hall; Lidewij Henneman; Heidi C Howard; Anneke Lucassen; Kelly Ormond; Borut Peterlin; Dragica Radojkovic; Wolf Rogowski; Maria Soller; Aad Tibben; Lisbeth Tranebjærg; Carla G van El; Martina C Cornel
Journal:  Eur J Hum Genet       Date:  2015-03-18       Impact factor: 4.246

Review 7.  Has noninvasive prenatal testing impacted termination of pregnancy and live birth rates of infants with Down syndrome?

Authors:  Melissa Hill; Angela Barrett; Mahesh Choolani; Celine Lewis; Jane Fisher; Lyn S Chitty
Journal:  Prenat Diagn       Date:  2017-12       Impact factor: 3.050

8.  What Do Parents of Children with Down Syndrome Think about Non-Invasive Prenatal Testing (NIPT)?

Authors:  Rachèl V van Schendel; Adriana Kater-Kuipers; Elsbeth H van Vliet-Lachotzki; Wybo J Dondorp; Martina C Cornel; Lidewij Henneman
Journal:  J Genet Couns       Date:  2016-09-13       Impact factor: 2.537

9.  Facilitating informed choice about non-invasive prenatal testing (NIPT): a systematic review and qualitative meta-synthesis of women's experiences.

Authors:  Alexandra Cernat; Chante De Freitas; Umair Majid; Forum Trivedi; Caroline Higgins; Meredith Vanstone
Journal:  BMC Pregnancy Childbirth       Date:  2019-01-14       Impact factor: 3.007

10.  Implementation challenges for an ethical introduction of noninvasive prenatal testing: a qualitative study of healthcare professionals' views from Lebanon and Quebec.

Authors:  Hazar Haidar; Meredith Vanstone; Anne-Marie Laberge; Gilles Bibeau; Labib Ghulmiyyah; Vardit Ravitsky
Journal:  BMC Med Ethics       Date:  2020-02-10       Impact factor: 2.652

View more
  2 in total

Review 1.  CRISPR-Cas and Its Wide-Ranging Applications: From Human Genome Editing to Environmental Implications, Technical Limitations, Hazards and Bioethical Issues.

Authors:  Roberto Piergentili; Alessandro Del Rio; Fabrizio Signore; Federica Umani Ronchi; Enrico Marinelli; Simona Zaami
Journal:  Cells       Date:  2021-04-21       Impact factor: 7.666

2.  Risk Assessment of the Increased Occurrence of Congenital Cardiac and Non-Cardiac Defects in Fetuses with a Normal Karyotype after Assisted Fertilization in Comparison to Natural Fertilization Based on Ultrasound Diagnostics.

Authors:  Dawid Serafin; Beniamin Oskar Grabarek; Dariusz Boroń; Andrzej Madej; Bartosz Czuba
Journal:  J Clin Med       Date:  2021-11-29       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.